News
18h
KCEN-TV on MSNRadiantPath Health launches nation's first mobile cancer treatment unitThe mobile units address critical access barriers by bringing FDA-approved targeted therapy directly to local clinics and communities through equipped RVs.
Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies ...
The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...
The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results